The use of β-adrenergic blocking drugs in patients with myocardial infarction
- 1 June 1984
- journal article
- clinical trial
- Published by Elsevier in Current Problems in Cardiology
- Vol. 9 (3) , 3-50
- https://doi.org/10.1016/0146-2806(84)90015-x
Abstract
No abstract availableFunding Information
- National Institutes of Health
This publication has 95 references indexed in Scilit:
- β-Adrenergic Blockade for Survivors of Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Predictability of Sudden Cardiac DeathNew England Journal of Medicine, 1984
- Reduction of Infarct Size with the Early Use of Timolol in Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983
- A Long-Term Prevention Study with Oxprenolol in Coronary Heart DiseaseNew England Journal of Medicine, 1982
- Ventricular Antiarrhythmic Effects of Beta‐Adrenergic Blocking Drugs: A Review of Mechanism and Clinical StudiesThe Journal of Clinical Pharmacology, 1982
- Nadolol: A New β-Adrenoceptor AntagonistNew England Journal of Medicine, 1981
- Myocardial IschemiaNew England Journal of Medicine, 1977
- Myocardial IschemiaNew England Journal of Medicine, 1977
- Myocardial IschemiaNew England Journal of Medicine, 1977